ANTI-HBV SPECIFIC β-L-2′-DEOXYNUCLEOSIDES

REFERENCES

• Graciet , J. C.G. and Schinazi , R. F. 1999 . From D- to L-nucleoside analogs as antiviral agents . Adv. Antiviral Drug Design , 3 : 1 – 68 .
   Google Scholar
• Gosselin , G. and et al. 1994 . Enantiomeric 2′,3′-dideoxycytidine derivatives are potent human immunodeficiency virus inhibitors in cell culture . C. R. Acad. Sci. Paris , 317 : 85 – 89 .
   PubMed Web of Science ®Google Scholar
• Schinazi , R. F. and et al. 1992 . Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine . Antimicrob. Agents Chemother. , 36 ( 11 ) : 2423 – 31 .
   PubMed Web of Science ®Google Scholar
• Shi , J. and et al. 1999 . Synthesis and biological evaluation of 2′,3′,-didehydro-2′,3′-dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase . J. Med. Chem. , 42 ( 5 ) : 859 – 67 .
   PubMedGoogle Scholar
• Bolon , P. J. and et al. 1996 . Anti-human immunodeficiency and anti-hepatitis B virus activities of beta-L-2′,3′-dideoxy purine nucleosides . Bioorg. Med. Chem. Lett. , 6 ( 14 ) : 1657 – 1662 .
   Google Scholar
• Gosselin , G. and et al. 1997 . New unnnatural L-nucleoside enantiomers: From their stereoselective synthesis to their biological activities . Nucleosides Nucleotides , 16 ( 7–9 ) : 1389 – 1398 .
   Google Scholar
• Chu , C. K. and et al. 1995 . Use of 2′-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus . Antimicrob. Agents Chemother. , 39 ( 4 ) : 979 – 81 .
   PubMedGoogle Scholar
• Placidi , L. and et al. 2000 . Intracellular metabolism of β-L-2′,3′-dideoxyadenosine: Relavance to its limited antiviral activity . Antimicrob. Agents Chemother. , 44 : 853 – 858 .
   PubMedGoogle Scholar
• Faulds , D. and Brogden , R. N. 1992 . Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection . Drugs , 44 ( 1 ) : 94 – 116 .
   PubMedGoogle Scholar
• Hurst , M. and Noble , S. 1999 . Stavudine: an update of its use in the treatment of HIV infection . Drugs , 58 ( 5 ) : 919 – 49 .
   PubMed Web of Science ®Google Scholar
• Whittington , R. and Brogden , R. N. 1992 . Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS) . Drugs , 44 ( 4 ) : 656 – 83 .
   PubMedGoogle Scholar
• Wilde , M. I. and Langtry , H. D. 1993 . Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy . Drugs , 46 ( 3 ) : 515 – 78 .
   PubMedGoogle Scholar
• Semizarov , D. G. and et al. 1997 . Stereoisomers of deoxynucleoside 5′-triphosphates as substrates for template-dependent and -independent DNA polymerases . J. Biol. Chem. , 272 ( 14 ) : 9556 – 60 .
   PubMedGoogle Scholar
• Verri , A. and et al. 1997 . Lack of enantiospecificity of human 2′-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents . Mol. Pharmacol. , 51 ( 1 ) : 132 – 8 .
   PubMedGoogle Scholar
• Faraj , A. and et al. 1994 . Effects of 2′,3′-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis . Antimicrob. Agents Chemother. , 30 ( 5 ) : 924 – 930 .
   Google Scholar
• Sommadossi , J.-P. , Carlisle , R. and Zhou , Z. 1989 . Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells . Mol. Pharmacol. , 36 ( 1 ) : 9 – 14 .
   PubMedGoogle Scholar
• Focher , F. and et al. 1995 . Stereospecificity of human DNA polymerases alpha, beta, gamma, delta and epsilon, HIV-reverse transcriptase, HSV-1 DNA polymerase, calf thymus terminal transferase and Escherichia coli DNA polymerase I inrecognizing D- and L-thymidine 5′-triphosphate as substrate . Nucleic Acids Res. , 23 ( 15 ) : 2840 – 7 .
   PubMedGoogle Scholar
• Spadari , S. and et al. 1992 . L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth . J. Med. Chem. , 35 ( 22 ) : 4214 – 20 .
   PubMedGoogle Scholar
• Chang , C. N. and et al. 1992 . Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/−)-2′,3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication . J. Biol. Chem. , 267 ( 20 ) : 13938 – 42 .
   PubMedGoogle Scholar
• Furman , P. A. and et al. 1992 . The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (−) and (+) enantiomers of cis-5-fluoro-1-[2- (hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine . Antimicrob. Agents Chemother. , 36 ( 12 ) : 2686 – 92 .
   PubMed Web of Science ®Google Scholar
• Martin , L. T. and et al. 1997 . Effect of stereoisomerism on the cellular pharmacology of beta-enantiomers of cytidine analogs in Hep-G2 cells . Biochem. Pharmacol. , 53 ( 1 ) : 75 – 87 .
   PubMedGoogle Scholar
• Chen , C. H. and Cheng , Y. C. 1989 . Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine . J Biol Chem , 264 ( 20 ) : 11934 – 7 .
   PubMed Web of Science ®Google Scholar
• Cui , L. and et al. 1997 . Mitochondrial DNA effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells . J. Pharmacol. Exp. Therap. , 280 : 1228 – 1234 .
   PubMedGoogle Scholar
• Cui , L. and et al. 1996 . Effect of β-enantiomeric and racemic nucleoside analogues on mitochondrial funtions in HepG2 cells . Biochem. Pharmacol. , 52 : 1577 – 1584 .
   PubMed Web of Science ®Google Scholar
• Cui , L. and et al. 1995 . Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-β-D-arabinofuranoxyl)-5-iodouracil in human liver cells . J. Clin. Invest. , 95 : 555 – 563 .
   PubMed Web of Science ®Google Scholar
• Dalakas , M. C. and et al. 1990 . Mitochondrial myopathy caused by long-term zidovudine therapy . N. Engl. J. Med. , 322 ( 16 ) : 1098 – 105 .
   PubMed Web of Science ®Google Scholar
• Lewis , W. and et al. 1992 . Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria . J. Clin. Invest. , 89 ( 4 ) : 1354 – 60 .
   PubMed Web of Science ®Google Scholar
• Pan-Zhou , X. R. and et al. 1999 . Differential effects of antiretroviral nucleoside analogs on mitochondrial function; dual inhibition of citrate synthase and cytochrome c oxidase by AZT . Antimicrob. Agents Chemother. , 44 : 496 – 503 .
   Google Scholar
• Lewis , W. and et al. 1996 . Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitchondrial structural defects in cultured hepatoblasts . Proc. Natl. Acad. Sci. USA , 93 ( 8 ) : 3592 – 7 .
   PubMedGoogle Scholar
• Tennant , B. C. and et al. 1998 . Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection . Hepatology , 128 ( 1 ) : 179 – 91 .
   Google Scholar
• Korba , B. E. and et al. 2000 . Treatment of chronic woodchuck hepatitis virus infection in the eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans . Hepatology , 31 ( 5 ) : 1165 – 75 .
   PubMedGoogle Scholar
• Cote , R. J. and et al. 1993 . New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection . Viral Immunology , 6 ( 2 ) : 161 – 9 .
   PubMedGoogle Scholar
• Genovesi , E. V. and et al. 1998 . Efficacy of the carbocyclic 2′-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection . Antimicrob. Agents Chemother. , 42 ( 12 ) : 3209 – 17 .
   PubMed Web of Science ®Google Scholar
• Mason , W. S. and et al. 1998 . Lamivudine therapy of WHV-infected woodchucks . Virology , 245 : 18 – 32 .
   PubMed Web of Science ®Google Scholar
• Rajagopalan , P. and et al. 1996 . Pharmacokinetics of (−)-2′-3′-dideoxy-3′-thiacytidine in woodchucks . Antimicrob. Agents Chemother. , 40 ( 3 ) : 642 – 5 .
   PubMedGoogle Scholar
• van Leeuwen , R. and et al. 1992 . The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection: a phase I study . Aids , 6 ( 12 ) : 1471 – 5 .
   PubMed Web of Science ®Google Scholar
• Richardson , F. C. , Engelhardt , J. A. and Bowsher , R. R. 1994 . Fialuridine accumulates in DNA of dogs, monkeys, and rats following long-term oral administration . Proc. Natl. Acad. Sci. USA , 91 ( 25 ) : 12003 – 7 .
   PubMedGoogle Scholar
• McKenzie , R. and et al. 1995 . Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B . N. Engl. J. Med. , 333 ( 17 ) : 1099 – 1105 .
   PubMed Web of Science ®Google Scholar